Cabot (NYSE:CBT) Updates FY 2025 Earnings Guidance

Cabot (NYSE:CBT) updated its FY 2025 earnings guidance on Monday. The company provided EPS guidance of 7.400-7.800 for the period, compared to the consensus EPS estimate of 7.640. The company issued revenue guidance of -.

Cabot Stock Down 2.0 %

CBT traded down $1.69 on Monday, hitting $84.78. The company had a trading volume of 508,517 shares, compared to its average volume of 356,892. The stock has a market capitalization of $4.60 billion, a price-to-earnings ratio of 12.58, a P/E/G ratio of 0.74 and a beta of 1.19. The stock has a fifty day moving average price of $95.85 and a 200-day moving average price of $102.13. Cabot has a 12-month low of $70.63 and a 12-month high of $117.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.36 and a current ratio of 2.08.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.80 EPS for the quarter, missing the consensus estimate of $1.81 by ($0.01). The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $1.01 billion. Cabot had a return on equity of 26.60% and a net margin of 9.51%. The company’s revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the firm earned $1.65 EPS. Analysts predict that Cabot will post 7.67 EPS for the current fiscal year.

Cabot Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be issued a dividend of $0.43 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $1.72 annualized dividend and a dividend yield of 2.03%. Cabot’s dividend payout ratio is presently 25.52%.

Cabot declared that its Board of Directors has authorized a stock buyback program on Tuesday, December 3rd that allows the company to buyback 10,000,000 outstanding shares. This buyback authorization allows the specialty chemicals company to purchase shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

CBT has been the subject of a number of research analyst reports. Mizuho decreased their price target on Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a research note on Tuesday, January 7th. JPMorgan Chase & Co. cut shares of Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 target price for the company. in a research note on Monday, November 11th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $102.00.

Insider Activity at Cabot

In other news, CAO Lisa M. Dumont sold 865 shares of the stock in a transaction dated Wednesday, November 13th. The shares were sold at an average price of $111.74, for a total transaction of $96,655.10. Following the sale, the chief accounting officer now directly owns 9,742 shares of the company’s stock, valued at $1,088,571.08. This represents a 8.15 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Hobart Kalkstein sold 34,759 shares of Cabot stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $115.23, for a total value of $4,005,279.57. Following the completion of the transaction, the executive vice president now owns 50,627 shares of the company’s stock, valued at approximately $5,833,749.21. This represents a 40.71 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,190 shares of company stock worth $5,751,534 over the last three months. Company insiders own 3.03% of the company’s stock.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.